Lazard Asset Management
AMED

Lazard Asset Management’s Amedisys AMED Stock Holding History

Lazard Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,144
Closed -$1.39M – 1832
2025
Q2 		$1.39M Buy
14,144
+7,961
+129% +$753K ﹤0.01% 1151
2025
Q1 		$572K Buy
6,183
+4,438
+254% +$409K ﹤0.01% 1370
2024
Q4 		$158K Sell
1,745
-553
-24% -$50.8K ﹤0.01% 1674
2024
Q3 		$221K Buy
+2,298
New +$224K ﹤0.01% 1583
2023
Q1 		– Sell
-399
Closed -$33K – 2282
2022
Q4 		$33K Hold
399
– – ﹤0.01% 1976
2022
Q3 		$38K Hold
399
– – ﹤0.01% 1904
2022
Q2 		$41K Hold
399
– – ﹤0.01% 1896
2022
Q1 		$68K Buy
+399
New +$59.6K ﹤0.01% 1577
2021
Q4 		– Sell
-302
Closed -$45K – 2273
2021
Q3 		$45K Buy
+302
New +$62.8K ﹤0.01% 1723
2020
Q1 		– Sell
-12
Closed -$2K – 1570
2019
Q4 		$2K Sell
12
-168
-93% -$25K ﹤0.01% 1464
2019
Q3 		$23K Buy
+180
New +$23.4K ﹤0.01% 1054

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lazard Asset Management's AMED Position: Q3 2025 in Review

Lazard Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,144 shares — an estimated $1.39M sold.

Lazard Asset Management first reported a position in AMED in Q3 2019 and held it in 11 quarters. The position peaked at $1.39M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Lazard Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 14,144 Amedisys shares in Q3 2025, an estimated $1.39M.
  • Lazard Asset Management first reported a position in Amedisys in Q3 2019 and held it in 11 quarters.
  • Lazard Asset Management's Amedisys position peaked at $1.39M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.